NI
EW icon

Natural Investments’s Edwards Lifesciences EW Stock Holding History

Natural Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$583K Buy
6,450
+950
+17% +$79.6K 0.13% 139
2026
Q1 		$440K Buy
5,500
+588
+12% +$48.5K 0.11% 172
2025
Q4 		$418K Sell
4,912
-176
-3% -$14.4K 0.1% 173
2025
Q3 		$395K Sell
5,088
-9
-0.2% -$703 0.1% 159
2025
Q2 		$398K Buy
5,097
+156
+3% +$11.6K 0.1% 165
2025
Q1 		$358K Sell
4,941
-362
-7% -$25.9K 0.1% 171
2024
Q4 		$392K Buy
+5,303
New +$371K 0.11% 163

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Natural Investments's EW Position: Q2 2026 in Review

Natural Investments increased its Edwards Lifesciences (EW) stake by 17% in Q2 2026, buying an estimated $79.6K and bringing the position to 6,450 shares worth $583K. The position accounts for 0.13% of the portfolio, ranked #139.

Natural Investments first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Natural Investments held 6,450 shares of Edwards Lifesciences worth $583K as of Q2 2026.
  • Natural Investments bought 950 Edwards Lifesciences shares in Q2 2026, an estimated $79.6K.
  • Edwards Lifesciences made up 0.13% of Natural Investments's portfolio in Q2 2026, its #139 holding.
  • Natural Investments first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.